Randomized, double-blind, placebo-controlled trial: Effect of lactobacillus GG supplementation on helicobacter pylori eradication rates and side effects during treatment in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 4, 2009, Pages 431-436

  Szajewska, Hania ^a   Albrecht, Piotr ^a   Topczewska Cabanek, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Microbiota; Probiotics

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; MALTODEXTRIN; OMEPRAZOLE; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; COLONY FORMING UNIT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; ERADICATION THERAPY; FEMALE; FLATULENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTOBACILLUS; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TASTE DISORDER; TREATMENT DURATION; UREA BREATH TEST; VOMITING;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHILD; CLARITHROMYCIN; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS; MALE; OMEPRAZOLE; PLACEBOS; PROBIOTICS;

HELICOBACTER PYLORI; LACTOBACILLUS;

EID: 67650915094     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318182e716     Document Type: Article

References (25)

1. Gold BD, Colletti RB, Abbott M, et al., North American Society for Pediatric Gastroenterology and Nutrition Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
2. Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helico-bacter pylori infection in children and adolescents: an evidence-based evaluation. Can J Gastroenterol 2005;19:399-408.
3. Koletzko S, Richy F, Bontems P, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006;55:1711-6.
4. Oderda G, Shcherbakov P, Bontems P, et al. European Pediatric Task Force on Helicobacter pylori: results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12:150-6.
5. Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007;25:155-68.
6. Bhatia SJ, Kochar N, Abraham P, et al. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30.
7. Bernet MF, Brassart D, Neeser JR, et al. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-9.
8. Sykora J, Valeckova K, Amlerova J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacil-lus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005;39:692-8.
9. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy:a pilot study. Digestion 2001;63:1-7.
10. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001;15:163-9.
11. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002;97:2744-9.
12. Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo controlled trial. Mayo Clin Proc 2001;76:883-9.
13. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999;135:564-8.
14. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104: e64.
15. Rowland M, Lambert I, Gormally S, et al. Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children. J Pediatr 1997;131:815-20.
16. Bode G, Rothenbacher D, Brenner H, et al. Variation in the 13Curea breath test value by nationality in Helicobacter pylori-infected children. Scand J Gastroenterol 1998;33:468-72.
17. Ciok J, Tacikowski T, Dzieniszewski J. Urea breath test (UBT) in the diagnosis of Helicobacter pylori infection [in Polish]. Gastroenterologia 2003;10:241-6.
18. Cave DR, Zanten SV, Carter E, et al. A multicentre evaluation of the laser assisted ratio analyser (LARA): a novel device for measurement of 13CO2 in the 13C-urea breath test for the detection of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13: 747-52.
19. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999;319: 670-4.
20. Lee YK, Salminen S. The coming age of probiotics. Trends Food Sci Technol 1995;6:241-5.
21. Gawrońska A, Dziechciarz P, Horvath A, et al. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007;25:177-84.
22. Goldin BR, Gorbach SL, Saxelin M, et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-8.
23. Goldman CG, Barrado DA, Balcarce N, et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006;22:984-8.
24. Lionetti E, Miniello VL, Castellaneta SP, et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006;24:1461-8.
25. Stone AA, Shiffman S, Schwartz JE, et al. Patient non-compliance with paper diaries. Br Med J 2002;324:1193-4.